GISONDI, Paolo
 Distribuzione geografica
Continente #
EU - Europa 6.471
NA - Nord America 6.278
AS - Asia 1.908
OC - Oceania 59
SA - Sud America 47
AF - Africa 23
Continente sconosciuto - Info sul continente non disponibili 4
Totale 14.790
Nazione #
US - Stati Uniti d'America 6.231
GB - Regno Unito 1.807
IT - Italia 1.354
CN - Cina 1.298
IE - Irlanda 633
FR - Francia 573
SE - Svezia 540
RU - Federazione Russa 498
DE - Germania 373
FI - Finlandia 343
SG - Singapore 327
UA - Ucraina 119
TR - Turchia 67
AU - Australia 52
ES - Italia 40
NL - Olanda 35
JP - Giappone 34
HK - Hong Kong 33
IN - India 31
CA - Canada 28
BR - Brasile 27
BE - Belgio 26
KR - Corea 21
CH - Svizzera 20
IR - Iran 20
PL - Polonia 19
MX - Messico 16
CZ - Repubblica Ceca 14
MY - Malesia 13
DK - Danimarca 12
AT - Austria 11
CL - Cile 11
EG - Egitto 8
ID - Indonesia 8
RO - Romania 8
SA - Arabia Saudita 8
KZ - Kazakistan 7
NZ - Nuova Zelanda 7
TH - Thailandia 7
VN - Vietnam 7
DZ - Algeria 6
HR - Croazia 6
PH - Filippine 6
PT - Portogallo 6
IL - Israele 5
IS - Islanda 5
ET - Etiopia 4
HU - Ungheria 4
LK - Sri Lanka 4
AL - Albania 3
BG - Bulgaria 3
CO - Colombia 3
EE - Estonia 3
EU - Europa 3
GR - Grecia 3
LV - Lettonia 3
MA - Marocco 3
NO - Norvegia 3
AM - Armenia 2
BO - Bolivia 2
EC - Ecuador 2
JO - Giordania 2
LU - Lussemburgo 2
PK - Pakistan 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AD - Andorra 1
AR - Argentina 1
BZ - Belize 1
FK - Isole Falkland (Malvinas) 1
GT - Guatemala 1
KE - Kenya 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
OM - Oman 1
PR - Porto Rico 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SM - San Marino 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 14.790
Città #
Southend 1.591
Chandler 1.055
Jacksonville 952
Dublin 622
Woodbridge 551
Ann Arbor 431
Houston 428
Ashburn 422
Beijing 245
Wilmington 220
Lawrence 215
Princeton 215
Singapore 196
Jinan 131
Nanjing 129
New York 114
Milan 104
Shenyang 97
Sindelfingen 94
Verona 87
Helsinki 71
Rome 70
Hebei 63
Haikou 53
Washington 48
Seattle 46
Tianjin 46
Nanchang 44
Changsha 43
Redwood City 42
Guangzhou 37
Hangzhou 34
Zhengzhou 33
Dallas 32
Jiaxing 32
Boardman 31
Falls Church 29
Kent 29
Bologna 28
Ningbo 28
Chicago 27
Redmond 27
Hong Kong 26
Brussels 25
Esslingen am Neckar 25
Los Angeles 25
Fairfield 22
Taizhou 22
Norwalk 21
Venice 20
Seoul 19
Turin 19
Sydney 18
Düsseldorf 17
Dongguan 16
Florence 16
Lancaster 16
Fuzhou 15
Amsterdam 14
Tokyo 14
Genoa 13
Kuala Lumpur 13
London 13
Enfield 12
Lappeenranta 12
Madrid 12
Moscow 12
Taiyuan 12
Bari 11
Brescia 11
Naples 11
Palermo 11
Phoenix 11
Vicenza 11
Atlanta 10
Frankfurt am Main 10
Shanghai 10
Toronto 10
Catania 9
Edinburgh 9
Lanzhou 9
Perth 9
San Jose 9
Trieste 9
Vienna 9
Canberra 8
Mersin 8
Warsaw 8
Almaty 7
Copenhagen 7
Las Rozas de Madrid 7
Nova Iguaçu 7
Santiago 7
Zurich 7
Cairo 6
Casaloldo 6
Dearborn 6
Las Vegas 6
Mexico City 6
Mumbai 6
Totale 9.512
Nome #
Pemfigoide cicatriziale di Brunsting-Perry: descrizione di un caso. 562
Interstitial granulomatous dermatitis: a distinct entity withcharacteristic histological and clinical pattern 309
La “Cross Unit”, una nuova modalità per ottimizzare il trattamento topico della psoriasi 299
Dietary supplements for lipedema 197
A itchy vesiculobullous eruption in a patient with chronic lymphocytic leukemia. 107
State of the art and pharmacological pipeline of biologics for chronic plaque psoriasis. 104
Impact of TNF-α antagonists on the quality of life in selected skin diseases 103
The early psoriatic arthritis screening questionnaire: a simple and fast method for the identification of arthritis in patients with psoriasis 102
Squamous cell carcinoma arising in lupus vulgaris. 100
Tossicodermia indotta da oxcarbamazepina: descrizione di un caso. 100
Latent tuberculosis infection in patients with chronic plaque psoriasis who are candidates for biological therapy 100
Psoriasis patients with nail disease have a greater magnitude of underlying systemic subclinical enthesopathy than those with normal nails. 97
Prevalence of psoriatic arthritis and joint complaints in a large population of Italian patients hospitalised for psoriasis 97
H1 histamine receptor mediates inflammatory responses in human keratinocytes. 97
Steatosi epatica non alcolica in pazienti con psoriasi cronica in placche. 97
Vitamin D levels in patients with psoriasis with or without arthritis 97
Polymorphisms, diet and nutrigenomics 96
Severe impairment of quality of life in Hailey-Hailey disease. 95
Nonalcoholic fatty liver disease in patients with chronic plaque psoriasis. 94
Survival rate of antitumour necrosis factor-a treatments for psoriasis in routine dermatological practice: a multicentre observational study 92
Il ruolo della vitamina D nella dermatite atopica 89
Retention rate of systemic drugs in patients with chronic plaque psoriasis 87
Lebbra lepromatosa. 86
Prevalence of symptoms experienced by patients with different clinical types of psoriasis. 86
Combining etanercept and acitretin in the therapy of chronic plaque psoriasis: a 24-week, randomized, controlled, investigator-blinded pilot trial 83
The expectations of patients with psoriasis during an office consultation 83
Treatment of recalcitrant scleromyxedema with thalidomide in 3 patients. 82
Targeting TNF-a in psoriasis and psoriatic arthritis. 81
Incidence of respiratory and allergic symptoms in Italian and immigrant children 81
Heat urticaria: a revision of published cases with an update on classification and management 81
Pimecrolimus in dermatology: atopic dermatitis and beyond. 80
Psoriasis, the liver, and the gastrointestinal tract 80
Balneotherapy for atopic dermatitis in children at Comano spa in Trentino, Italy 80
Attitude to treatment of patients with psoriasis attending SPA center 80
The efficacy and safety of topical pimecrolimus in pediatric patients with atopic dermatitis. 79
Weight reduction alone may not be sufficient to maintain disease remission in obese patients with psoriasis: a randomized, investigator-blinded study. 79
The link between enthesitis and arthritis in psoriatic arthritis: a switch to a vascular phenotype at insertions may play a role in arthritis development. 78
Advanced Glycation End Products in the Pathogenesis of Psoriasis 78
Psoriasi. Una guida per una migliore gestione del paziente. 77
Effective management of psoriasis symptom worsening durino efalizumab therapy without discontinuing treatment: A case study. 77
Erythema nodosum: etiological factors and relapses in a retrospective cohort study. 77
Mild cognitive impairment in patients with moderate to severe chronic plaque psoriasis 77
Lower limbs enthesopathy in psoriasic patients without clinical signs of arthropathy: a bospital based case-control study. 76
Acneiform eruption induced by cetuximab 76
Psoriasis and the metabolic syndrome 76
Balneotherapy for chronic plaque psoariasis at Comano spa in Trentino, Italy. 75
Ustekinumab does not increase body mass index in patients with chronic plaque psoriasis: a prospective cohort study 75
The diagnostic and therapeutic challenge of early psoriatic arthritis 75
Prevalence of psoriatic arthritis and joint complaints in a large population of Italian patients hospitalised for psoriasis. 74
New insights into the autoantibody-mediated mechanisms of autoimmune bullous diseases and urticaria. 73
Efficacy and safety of secukinumab in chronic plaque psoriasis and psoriatic arthritis therapy 73
Apremilast in the therapy of moderate-to-severe chronic plaque psoriasis 73
C-reactive protein and markers for thrombophilia in patients with chronic plaque psoriasis 72
A randomized controlled trial to evaluate short-term treatment with eosin vs. topical steroids in psoriasis. 72
The importance of treating mild atopic dermatitis. 71
The metabolic syndrome in psoriasis 71
Non-alcoholic fatty liver disease fibrosis score in patients with psoriasis 71
Preliminary evidence that subclinical enthesopathy may predict psoriatic arthritis in patients with psoriasis 71
Hyperuricaemia in patients with chronic plaque psoriasis. 71
Patients with psoriasis have a higher prevalence of parental cardiovascular disease 70
Effects of secukinumab on serum adipocytokines: preliminary data 70
Image Gallery: Pyoderma gangrenosum of the penis. 70
Dermatite atopica. 69
Complicanze dell'obesità: la cute 69
Insufficient knowledge among psoriasis patients can represent a barrier to participation in decision-making. 69
Imaging in psoriasis and psoriatic arthritis: GRAPPA 2008. 69
PSORIASIS 69
Chronic plaque psoriasis is associated with increased arterial stiffness 68
Metabolic comorbidities and psoriasis. 68
Biologic therapies in psoriasis: a new therapeutic approach 68
Autoimmune progesterone dermatitis. 67
L’organo pelle: struttura, biologia, funzioni. 67
Imiquimod: un ruolo nel trattamento topico della epidermodisplasia verruciforme? 66
Serum chemerin is increased in patients with chronic plaque psoriasis and normalizes following treatment with infliximab. 66
Dose adjustment of biologic therapies for psoriasis in dermatological practice: a retrospective study 66
Psodisk, a new visual method for assessing the burden of psoriasis on patients. 65
Systemic therapy of psoriasis in diabetic patients 65
Le malattie della mucosa orale 64
Targeting tumor necrosis factor a in the therapy of psoriasis. 64
Immunoregulation of allergic contact dermatitis. 63
Plasma homocysteine and folate levels in patients with chronic plaque psoriasis. 63
Microcircolatory modifications of psoriatic lesions during topical therapy. 63
Vitamin D status in patients with chronic plaque psoriasis 63
Autoantibody induction and adipokine levels in patients with psoriasis treated with infliximab. 63
Ultrasonography of the nail unit reveals quantitative and qualitative alterations in patients with psoriasis and psoriatic arthritis 63
TNF-α inhibitors biosimilars as first line systemic treatment for moderate-to-severe chronic plaque psoriasis 63
Usefulness of the Framingham risk score in patients with chronic psoriasis 62
Aggiornamento sulla terapie biologiche della psoriasi 61
Weight loss improves the response of obese patients with moderate-to-severe chronic plaque psoriasis to low-dose cyclosporine therapy: a randomized, controlled, investigator-blinded clinical trial. 61
Annular Lichenoid Dermatitis of Youth: Report of Six New Cases with Review of the Literature 61
Perception of disease and doctor-patient relationship experienced by patients with psoriasis. A questionnaire-based study 60
The need for long-term continuous therapy in moderate to severe chronic plaque psoriasis 59
Phenotypes of atopic dermatitis 59
La dermatite atopica nella seconda infanzia ed adolescenza 59
Metabolic abnormalities associated with initiation of systemic treatment for psoriasis: evidence from the Italian Psocare Registry. 59
Anti-tumour necrosis factor-alpha therapy increases body weight in patients with chronic plaque psoriasis: a retrospective cohort study. 59
Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study. 59
Considerations for Systemic Treatment of Psoriasis in Obese Patients 59
Cardiometabolic comorbidities: the fingerprint of psoriasis 58
Latent tuberculosis infection in patients with chronic plaque psoriasis: evidence from the Italian Psocare Registry* 58
Totale 8.595
Categoria #
all - tutte 58.710
article - articoli 56.595
book - libri 228
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.887
Totale 117.420


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.241 0 28 23 120 104 206 142 98 104 147 98 171
2020/20211.571 130 295 66 168 199 198 42 100 100 27 184 62
2021/20221.439 86 230 38 121 88 91 54 109 79 55 125 363
2022/20233.859 269 238 357 605 270 889 66 195 503 213 182 72
2023/20242.540 119 198 241 282 262 403 149 158 35 110 344 239
2024/2025644 387 257 0 0 0 0 0 0 0 0 0 0
Totale 15.126